Brazil and Thailand become first malaria-endemic countries to launch new single-dose radical cure medicine to prevent the relapse of Plasmodium vivax malaria
Issued: London, UK
For media and investors only
Download
(PDF, 162.9KB)
Launch of single-dose tafenoquine, co-administered with chloroquine, is another step closer to global elimination of malaria
The development and launch of this new treatment...
Zur Pressemeldung auf www.gsk.com